Columnist Sam Kirton explains when the new FDA-approved IPF treatment Jascayd might be made available to patients.
Software that uses artificial intelligence to analyze medical imaging tests may help facilitate earlier diagnosis and more accurate monitoring of pulmonary fibrosis in people with underlying lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback